bwge2020 has ended

Create Your Own Event

bwge2020

08:00 CET

Breakfast Symposium EISAI/MSD Room TEUN

08:30 CET

Safety and preliminary efficacy of human adult liver progenitor cells (HepaStem™) in patients with acute-on-chronic liver failure (ACLF) or acute decompensation (AD) at risk of developing ACLF Room TEUN

08:40 CET

Viral hepatitis in Belgian prisons: a first-time multicenter prevalence study Room TEUN

08:50 CET

Hypoxia-induced angiogenesis protects the liver from small for size syndrome Room TEUN

09:00 CET

18F-Fluorocholine and 18F-Fluorodesoxyglucose PET/CT for Clinical Staging of patients with Hepatocellular Carcinoma Room TEUN

09:10 CET

Are liver inclusive intestinal grafts protected against rejection? Room TEUN

09:20 CET

Prevalence and characteristics of cystic fibrosis-associated liver disease in a cohort of adult cystic fibrosis patients Room TEUN

10:00 CET

Coffee Break Symposium BAYER Room TEUN

10:30 CET

Coffee Break Exposition Area

10:45 CET

Pitfalls of bariatric surgery in NAFLD and liver transplant patients Room TEUN

11:15 CET

Plasma protein glycomics combined with circulating fragments of cytokeratin-18 are reliable biomarkers to diagnose alcoholic hepatitis Room TEUN

11:26 CET

Long-term outcome of symptomatic alcoholic hepatitis with a Maddrey discriminant function < 32. Room TEUN

11:37 CET

The link between the gut and the liver during early alcoholic liver disease Room TEUN

11:48 CET

Role of the gut microbiota in the modulation of the gut-liver-brain axis in alcohol use disorders: proof of concept with the fecal microbiota transplantation Room TEUN

11:59 CET

Myosteatosis is associated with early NASH in the context of obesity and metabolic syndrome Room TEUN

12:10 CET

Hepatitis E Virus Genotype 3 subtype dependent clinical outcomes in Belgium 2010 – 2018 Room TEUN

12:21 CET

Transcriptome profiling of liver biopsies before antiviral treatment start can predict HCC development 8.3 years before clinical diagnosis in chronic Hepatitis B and C patients Room TEUN

12:35 CET

Lunch Exposition Area

13:15 CET

Satellite Symposium GILEAD Room TEUN

14:00 CET

Unlike HbA1c level and the amount of visceral adipose tissue, the presence and severity of NAFLD do not predict the occurrence of major adverse cardiovascular events in an obese Belgian population Room TEUN

14:10 CET

Do patients with NAFLD have an increased incidence of cardiovascular complications after liver transplantation? Room TEUN

14:20 CET

Alcoholic liver disease and liver transplantation in patients with prior bariatric surgery Room TEUN

14:30 CET

Efficacy of enteroscopy-assisted ERCP in liver transplant patients with Roux-en-Y reconstruction and suspected bile duct pathology. Room TEUN

14:40 CET

Prediction of mortality in cirrhotic patients before surgery Room TEUN

15:20 CET

Coffee Break Exposition Area

15:40 CET

Myeloid IRE1a deletion alters hepatic macrophage phenotype and attenuates experimental non-alcoholic steatohepatitis-related hepatocellular carcinoma Room TEUN

15:50 CET

Active Non-alcoholic steatohepatitis and severe fibrosis are associated with dysfunctional adipose tissue and worsen with more severe adipose tissue insulin resistance independently of Body mass index Room TEUN

16:00 CET

Muscle fat infiltration in obese patients is associated with NAFLD related fibrosis severity – results from a prospective body composition and imaging study Room TEUN

16:10 CET

The mechanisms of steatosis pathogenesis during NASH development Room TEUN

16:20 CET

Neutralizing anti-CD8 antibodies effectively reduce visceral adipose tissue cytotoxic T cells and attenuate NAFLD in a high-fat high-fructose diet mouse model Room TEUN

16:30 CET

Case-finding of Non-alcoholic fatty liver disease-induced liver fibrosis: prevalence and use of non-invasive scoring vs. transient elastography in primary care Room TEUN

16:40 CET

The effects of oral bosentan treatment on the increased intrahepatic vascular resistance and disease severity of early NAFLD in rats Room TEUN

16:50 CET

Impact of amino acid supplementation on sarcopenia in NASH Room TEUN

17:00 CET

Assessment of liver fibrosis stage in active NASH by VCT Room TEUN

17:15 CET

Satellite Symposium ALNYLAM Room TEUN

17:45 CET

BASL Prizes & General Assembly Room TEUN